v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Deficit [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Balance at Jan. 03, 2021   $ 389 $ 5,122 $ (3,303,492) $ (2,424)
Balance (in shares) at Jan. 03, 2021   38,868,350      
Net Income (Loss) $ 510,467     510,467  
Dividends declared on common stock and equivalents       (139,588)  
Issuance and cancellation of stock awards, net (in shares)   (1,994)      
Tax payments for restricted stock upon vesting     (6,820)    
Tax payments for restricted stock upon vesting, (in shares)   (14,826)      
Purchases of common stock   $ (30) (45,568) (1,275,304)  
Purchases of common stock, (in shares)   (2,912,558)      
Exercises of stock options   $ 2 19,680    
Exercises of stock options, (in shares) 199,301 199,301      
Non-cash equity-based compensation expense     28,670    
Other     (244)    
Currency translation adjustment         (396)
Balance at Jan. 02, 2022   $ 361 840 (4,207,917) (2,820)
Balance (in shares) at Jan. 02, 2022   36,138,273      
Net Income (Loss) $ 452,263     452,263  
Dividends declared on common stock and equivalents       (157,479)  
Issuance and cancellation of stock awards, net (in shares)   15,012      
Tax payments for restricted stock upon vesting     (10,349) (371)  
Tax payments for restricted stock upon vesting, (in shares)   (26,699)      
Purchases of common stock   $ (7) (12,819) (280,914)  
Purchases of common stock, (in shares)   (739,847)      
Exercises of stock options     3,312    
Exercises of stock options, (in shares) 32,979 32,979      
Non-cash equity-based compensation expense     28,709    
Currency translation adjustment         (1,874)
Balance at Jan. 01, 2023 $ (4,189,065) $ 354 9,693 (4,194,418) (4,694)
Balance (in shares) at Jan. 01, 2023 35,419,718 35,419,718      
Net Income (Loss) $ 519,118     519,118  
Dividends declared on common stock and equivalents       (170,419)  
Issuance and cancellation of stock awards, net (in shares)   33,947      
Tax payments for restricted stock upon vesting     (5,410)    
Tax payments for restricted stock upon vesting, (in shares)   (16,038)      
Purchases of common stock   $ (8) (47,651) (223,929)  
Purchases of common stock, (in shares)   (789,977)      
Exercises of stock options   $ 1 8,655    
Exercises of stock options, (in shares) 78,532 78,532      
Non-cash equity-based compensation expense     37,514    
Currency translation adjustment         827
Balance at Dec. 31, 2023 $ (4,070,367) $ 347 $ 2,801 $ (4,069,648) $ (3,867)
Balance (in shares) at Dec. 31, 2023 34,726,182 34,726,182